Avadel Pharmaceuticals Plc AVDL Financial and Strategic SWOT Analysis Review [Report Updated: 17102017] Prices from USD $125

05:14 EST 15 Nov 2017 | BioPortfolio Reports

Avadel Pharmaceuticals Plc AVDL Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Avadel Pharmaceuticals Plc Avadel, formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, CNS narcolepsy, pain, respiratory diseases and diabetes. The company's product portfolio includes Bloxiverz, Karbinal ER, AchipHex Sprinkle and Vazculep. It develops products based on its proprietary polymerbased technologies; Micropump oral sustained release microparticles platform, LiquiTime a Micropump derivative platform for liquid oral products, Medusa controlled release of injectables and for Trigger Lock a Micropump derivative platform abuse resistant opioids. The company has operations in the US St. Louis, Missouri, and Charlotte and Dublin, Ireland and markets its products in the US, France and Ireland. Avadel is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals Plc Key Recent Developments

Aug 08,2017: Avadel Pharmaceuticals Reports Second Quarter 2017 Results

May 09,2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results

Mar 30,2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce

Mar 07,2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results

Jan 05,2017: Avadel Pharmaceuticals Provides 2017 Guidance and Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Avadel Pharmaceuticals Plc AVDL Financial and Strategic SWOT Analysis Review [Report Updated: 17102017] Prices from USD $125


More From BioPortfolio on "Avadel Pharmaceuticals Plc AVDL Financial and Strategic SWOT Analysis Review [Report Updated: 17102017] Prices from USD $125"

Quick Search


Relevant Topics

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...